ArticleMolecular cancer therapeutics2026
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.
Kaiting Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMolecular cancer therapeutics2026
Kaiting Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.